Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase

Jeffrey T. Bagdanoff(Novartis (Switzerland)), Mika Lindvall, Daniel Poon(Rapt Therapeutics (United States)), Patrick S. Lee, Wooseok Han, Cornelia Bellamacina, Rama Jain
Bioorganic & Medicinal Chemistry Letters
June 25, 2015
Cited by 16


Related Papers